Global Update (non-endemic countries): As of 10 January 2023, 84,471 confirmed cases of mpox and 285 deaths were reported from 110 countries/territories globally. The countries reporting the majority of cases are mainly in Europe and the Americas.
Africa update (endemic and non-endemic countries): Since the beginning of 2022, the continent has reported 1,267 confirmed cases and 226 deaths (CFR: 17.8%) of mpox from eight endemic Africa Union (AU) Member States (MS): Benin (3 confirmed cases; 0 confirmed deaths), Cameroon (18; 3), Central African Republic (CAR) (13; 3), Congo (5; 3), Democratic Republic of Congo (DRC) (319; 204), Ghana (116; 4), Liberia (6; 0), Nigeria (756; 7) and five non-endemic MS: Egypt (4; 0), Morocco (3; 0), Mozambique (1; 1), South Africa (5; 0) and Sudan (18; 1). Five MS have not reported mpox cases in the last three months: Benin, Congo, Morocco, Sierra Leone and South Africa. This week, five new confirmed cases and no new deaths of mpox were reported from Liberia (2 cases; 0 deaths) and Nigeria (3; 0).
Liberia: Since the last update (4 November 2022), the MoH reported two new confirmed cases and no new deaths of mpox. There is a 100% increase in the number of new confirmed cases reported compared to the last update. Cumulatively, six confirmed cases and no deaths of mpox were reported from four counties: Grand Bassa, Montserrado, Maryland and Bomi.
Nigeria: Since the last update (23 December 2022), the Nigeria Center for Disease Control (NCDC) reported three new confirmed cases and no new deaths of mpox. This is a 94% decrease in the number of new confirmed cases reported compared to the last update. Cumulatively, 756 confirmed cases and seven deaths (CFR: 1%) of mpox were reported from 36 states and the federal capital.